George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNBLS.L Regulatory News (NBLS)

  • There is currently no data for NBLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

24 Aug 2020 09:12

RNS Number : 9599W
NB Global Floating Rate Income Fund
24 August 2020
 

NB Global Floating Rate Income: New research 

24/08/2020

Board proposals would see NBLS transformed into a high-income, monthly dividend payer…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAEAPPLAEPEEEA
Date   Source Headline
8th Sep 20206:30 pmRNSNet Asset Value(s)
8th Sep 20206:12 pmRNSResult of Meeting
7th Sep 20206:00 pmRNSNet Asset Value(s)
4th Sep 20206:00 pmRNSNet Asset Value(s)
3rd Sep 20206:00 pmRNSNet Asset Value(s)
3rd Sep 20204:57 pmRNSPosting of Interim Report
2nd Sep 20206:00 pmRNSNet Asset Value(s)
2nd Sep 20207:00 amRNSHalf-year Report
1st Sep 20206:00 pmRNSNet Asset Value(s)
28th Aug 20206:00 pmRNSNet Asset Value(s)
27th Aug 20206:00 pmRNSNet Asset Value(s)
26th Aug 20206:00 pmRNSNet Asset Value(s)
25th Aug 20206:14 pmRNSPortfolio Update - July 2020 - Replacement
25th Aug 20206:00 pmRNSNet Asset Value(s)
24th Aug 20206:00 pmRNSNet Asset Value(s)
24th Aug 20209:12 amRNSKepler Trust Intelligence: New Research
24th Aug 20207:00 amRNSPortfolio Update - July 2020
21st Aug 20206:00 pmRNSNet Asset Value(s)
20th Aug 20206:00 pmRNSNet Asset Value(s)
19th Aug 20206:00 pmRNSNet Asset Value(s)
18th Aug 20206:00 pmRNSNet Asset Value(s)
17th Aug 20206:00 pmRNSNet Asset Value(s)
17th Aug 20209:42 amRNSNotice of EGM
14th Aug 20206:00 pmRNSNet Asset Value(s)
13th Aug 20206:00 pmRNSNet Asset Value(s)
12th Aug 20206:00 pmRNSNet Asset Value(s)
11th Aug 20206:00 pmRNSNet Asset Value(s)
10th Aug 20206:00 pmRNSNet Asset Value(s)
7th Aug 20206:00 pmRNSNet Asset Value(s)
6th Aug 20206:00 pmRNSNet Asset Value(s)
5th Aug 20206:00 pmRNSNet Asset Value(s)
5th Aug 20203:13 pmRNSKepler Trust Intelligence: Analysis of proposals
5th Aug 20203:00 pmRNSChange in Investment Policy & Discount Control
4th Aug 20206:00 pmRNSNet Asset Value(s)
3rd Aug 20206:00 pmRNSNet Asset Value(s)
3rd Aug 20205:26 pmRNSTotal Voting Rights
31st Jul 20206:00 pmRNSNet Asset Value(s)
31st Jul 202011:14 amRNSConversion of Securities
30th Jul 20206:00 pmRNSNet Asset Value(s)
29th Jul 20206:00 pmRNSNet Asset Value(s)
28th Jul 20206:00 pmRNSNet Asset Value(s)
27th Jul 20206:00 pmRNSNet Asset Value(s)
24th Jul 20206:00 pmRNSNet Asset Value(s)
24th Jul 202012:26 pmRNSUpdate regarding dividend reinvestment plan
23rd Jul 20206:00 pmRNSNet Asset Value(s)
22nd Jul 20206:00 pmRNSNet Asset Value(s)
21st Jul 20206:00 pmRNSNet Asset Value(s)
20th Jul 20206:00 pmRNSNet Asset Value(s)
20th Jul 20205:32 pmRNSTermination of Voluntary Share Conversion Facility
20th Jul 20207:00 amRNSPortfolio Update - June 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.